In this study, we aimed to investigate the systemic inflammatory profile and serum Spp1 levels in patients with ALS and SBMA, and to examine the associations of Spp1 levels with clinical variables and other systemic inflammatory markers in motor neuron diseases (MNDs). This evidence concerns the gene SPP1 and Kennedy disease.